Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Molla Huq"'
Autor:
Ricardo Azêdo de Luca Montes, Molla Huq, Timothy Godfrey, Shereen Oon, Alicia Calderone, Rangi Kandane-Rathnayake, Worawit Louthrenoo, Shue-Fen Luo, Yeong-Jian Jan Wu, Vera Golder, Aisha Lateef, Sandra V. Navarra, Leonid Zamora, Laniyati Hamijoyo, Sargunan Sockalingam, Yuan An, Zhanguo Li, Yasuhiro Katsumata, Masayoshi Harigai, Madelynn Chan, Fiona Goldblatt, Sean O’Neill, Chak Sing Lau, Jiacai Cho, Alberta Hoi, Chetan S. Karyekar, Eric F. Morand, Mandana Nikpour
Publikováno v:
Advances in Rheumatology, Vol 64, Iss 1, Pp 1-10 (2024)
Abstract Background This study examines the association of standard-of-care systemic lupus erythematosus (SLE) medications with key outcomes such as low disease activity attainment, flares, damage accrual, and steroid-sparing, for which there is curr
Externí odkaz:
https://doaj.org/article/f7e9c10f10e44e0fa19fee087d51bc04
Autor:
Faisal Alasmari, Mahmoud Mukahal, Alaa Ashraf Alqurashi, Molla Huq, Fatima Alabdrabalnabi, Abdullah AlJurayyan, Shymaa Moshobab Alkahtani, Fatimah Salem Assari, Rahaf Bashaweeh, Rana Salam, Solaf Aldera, Ohud Mohammed Alkinani, Talal Almutairi, Kholoud AlEnizi, Imad Tleyjeh
Publikováno v:
PLoS ONE, Vol 17, Iss 8, p e0272818 (2022)
Seroprevalence of SARS-CoV-2 IgG among health care workers (HCWs) is crucial to inform infection control programs. Conflicting reports have emerged on the longevity of SARS-CoV-2 IgG. Our objective is to describe the prevalence of SARS-CoV-2 IgG in H
Externí odkaz:
https://doaj.org/article/0a87836abb294a7a9eb9c30314ca2fef
Autor:
Jayne Moxey, Molla Huq, Susanna Proudman, Joanne Sahhar, Gene-Siew Ngian, Jenny Walker, Gemma Strickland, Michelle Wilson, Laura Ross, Gabor Major, Janet Roddy, Wendy Stevens, Mandana Nikpour
Publikováno v:
Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-12 (2019)
Abstract Background Up to 12% of patients with systemic sclerosis (SSc) have anti-neutrophil cytoplasmic antibodies (ANCA). However, the majority of these patients do not manifest ANCA-associated vasculitis (AAV) and the significance of ANCA in these
Externí odkaz:
https://doaj.org/article/e2da2049f0364d7399a503fac0ef2cc5
Autor:
Kathleen Morrisroe, Wendy Stevens, Molla Huq, David Prior, Jo Sahhar, Gene-Siew Ngian, David Celermajer, Jane Zochling, Susanna Proudman, Mandana Nikpour, the Australian Scleroderma Interest Group (ASIG)
Publikováno v:
Arthritis Research & Therapy, Vol 19, Iss 1, Pp 1-10 (2017)
Abstract Background Pulmonary arterial hypertension (PAH) is a leading cause of mortality in systemic sclerosis (SSc). We sought to determine survival, predictors of mortality, and health-related quality of life (HRQoL) related to PAH in a large SSc
Externí odkaz:
https://doaj.org/article/d4c8d23868d749c08a685327102dcc3c
Publikováno v:
Contemporary Clinical Trials Communications, Vol 14, Iss , Pp - (2019)
Introduction: We conducted a double-blind randomised controlled trial in a remote-living Australian Aboriginal group at high risk for chronic disease to assess whether pharmacological treatment with angiotensin converting enzyme inhibitor (ACEi) coul
Externí odkaz:
https://doaj.org/article/459444d2d2d44067806f18f8a9acaf56
Autor:
Dylan Hansen, Joanne Sahhar, Susanna Proudman, Molla Huq, Christopher Hill, Nava Ferdowsi, Janet Roddy, Wendy Stevens, Jennifer G Walker, Mandana Nikpour, Gene-Siew Ngian, Kathleen Morrisroe
Publikováno v:
Arthritis Care & Research. 72:1625-1635
OBJECTIVE: To quantify the burden of cancer in systemic sclerosis (SSc). METHODS: Standardized incidence ratios (SIRs) and standardized mortality ratios relative to the general Australian population were derived. Cox proportional hazards regression w
Autor:
Alberta Hoi, Rangi Kandane-Rathnayake, Eric F Morand, Mandana Nikpour, Vera Golder, Edward R Hammond, Rachel Koelmeyer, H Nab, Ai Li Yeo, Molla Huq
Publikováno v:
Arthritis Care & Research. 72:1289-1295
OBJECTIVE: Treat-to-target end points for systemic lupus erythematosus (SLE) have been assessed for their impact on damage accrual and flare, but whether they have an impact on the high health care utilization and costs in SLE has not been studied. T
Autor:
Faisal Alasmari, Mahmoud Mukahal, Alaa Ashraf Alqurashi, Molla Huq, Fatima Alabdrabalnabi, Abdullah AlJurayyan, Shymaa Moshobab Alkahtani, Fatimah Salem Assari, Rahaf Bashaweeh, Rana Salam, Solaf Aldera, Ohud Mohammed Alkinani, Talal Almutairi, Kholoud AlEnizi, Imad Tleyjeh
Publikováno v:
PloS one. 17(8)
Seroprevalence of SARS-CoV-2 IgG among health care workers (HCWs) is crucial to inform infection control programs. Conflicting reports have emerged on the longevity of SARS-CoV-2 IgG. Our objective is to describe the prevalence of SARS-CoV-2 IgG in H
Autor:
Molla Huq, Hieu T. Nim, Alberta Hoi, Mandana Nikpour, Sean O'Neill, Fiona Goldblatt, Vera Golder, Rangi Kandane-Rathnayake, Madelynn Chan, Zhanguo Li, Yeong-Jian Jan Wu, Leonid Zamora, Masayoshi Harigai, Chak Sing Lau, Worawit Louthrenoo, Eric F Morand, Yasuhiro Katsumata, Aisha Lateef, Sandra V. Navarra, Sargunan Sockalingam, Laniyati Hamijoyo, Shue Fen Luo
Publikováno v:
The Lancet Rheumatology. 1:e95-e102
Summary Background Treat-to-target strategies have improved outcomes in single-organ diseases with simple clinical or laboratory endpoints. A lack of validated endpoints has prevented adoption of treat to target for complex multiorgan conditions, suc
Autor:
Sean O'Neill, Molla Huq, Mandana Nikpour, Rangi Kandane-Rathnayake, Laniyati Hamijoyo, Shue Fen Luo, Chak Sing Lau, Madelynn Chan, Zhanguo Li, Alberta Hoi, Yeong-Jian Jan Wu, Sandra V. Navarra, Masayoshi Harigai, Leonid Zamora, Worawit Louthrenoo, Yasuhiro Katsumata, Aisha Lateef, Eric F Morand, Vera Golder, Sargunan Sockalingam, Fiona Goldblatt
Publikováno v:
The Lancet Rheumatology. 1:e103-e110
Summary Background Validated outcome measures are needed from which to derive treatment strategies for systemic lupus erythematosus (SLE). However, no definition of remission for SLE has been widely adopted. The Definitions of Remission in Systemic L